Aldesleukin Completed Phase 1 Trials for Pineal Gland Astrocytoma / Brain Stem Gliomas / Anaplastic Meningioma / Gliosarcoma / Anaplastic Ependymoma / Meningeal Hemangiopericytoma / Mixed Gliomas / Giant Cell Glioblastoma / Ependymoblastoma / Glioblastomas / Anaplastic Oligodendroglioma (AO) / Grade III Meningioma / Anaplastic Astrocytoma (AA) / Neoplasms, Brain Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01082926Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2